DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

The Efficacy of Three Months-prednisolone Therapy for Chronic Eosinophilic Pneumonia

Information source: Hamamatsu University
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Eosinophilic Pneumonia; Chronic Disease

Intervention: prednisolone 0.5 mg/kg/day for three months (Drug); prednisolone 0.5 mg/kg/day for six months (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Hamamatsu University

Official(s) and/or principal investigator(s):
Kingo Chida, MD, PhD, Study Chair, Affiliation: Hamamatsu University


A comparison of 3 months-prednisolone administration with 6 months-prednisolone therapy in the treatment of chronic eosinophilic pneumonia. Three months-prednisolone administration may be as effective as 6 months-therapy.

Clinical Details

Official title: Phase 4, Randomized Study of Three Months-prednisolone Therapy in the Treatment of Chronic Eosinophilic Pneumonia

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: Efficacy of 3 versus 6 months-prednisolone therapy for chronic eosinophilic pneumonia

Secondary outcome: Safety of 3 versus 6 months-prednisolone therapy for chronic eosinophilic pneumonia


Minimum age: 16 Years. Maximum age: 80 Years. Gender(s): Both.


Inclusion Criteria:

- Biopsy-proven chronic eosinophilic pneumonia

Exclusion Criteria:

- Patients who received oral glucocorticosteroid (more than 10 mg)

- Immunosuppressive drug

Locations and Contacts

Hamamatsu University School of Medicine, Hamamatsu, Japan
Additional Information

Starting date: June 2008
Last updated: September 18, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017